June 2008
Advertisement
Advertisement
Trending on HCPLive
1
Omalizumab-Facilitated OIT Enables Maintenance Dosing in Food Allergy
2
VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes
3
After Sickle Cell Gene Therapy, What Comes Next?
4
Namilumab Fails to Meet Primary End Point in Pulmonary Sarcoidosis
5